HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) major shareholder Of America Corp /De/ Bank acquired 670 shares of the stock in a transaction dated Tuesday, July 26th. The stock was bought at an average cost of $27.97 per share, with a total value of $18,739.90. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
HCA Healthcare Stock Performance
Shares of HCA stock opened at $342.25 on Monday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The stock has a market capitalization of $84.26 billion, a P/E ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The firm’s 50 day moving average is $324.53 and its 200 day moving average is $340.92.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business posted $5.90 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Increases Dividend
Analyst Upgrades and Downgrades
HCA has been the topic of several recent analyst reports. KeyCorp dropped their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Barclays cut their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Bank of America decreased their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.
Read Our Latest Stock Report on HCA
Institutional Investors Weigh In On HCA Healthcare
Institutional investors and hedge funds have recently made changes to their positions in the business. Legacy Investment Solutions LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Whipplewood Advisors LLC bought a new stake in HCA Healthcare during the fourth quarter valued at approximately $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $36,000. Activest Wealth Management grew its position in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. lifted its stake in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 03/24 – 03/28
- With Risk Tolerance, One Size Does Not Fit All
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.